Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities

Carla Marini, Davide Mei, Teresa Temudo, Anna Rita Ferrari, Daniela Buti, Charlotte Dravet, Ana I. Dias, Ana Moreira, Eulalia Calado, Stefano Seri, Brian Neville, Juan Narbona, Evan Reid, Roberto Michelucci, Federico Sicca, Helen J. Cross, Renzo Guerrini

Research output: Contribution to journalArticle

Abstract

Purpose: SCN1A is the most clinically relevant epilepsy gene, most mutations lead to severe myoclonic epilepsy of infancy (SMEI) and generalized epilepsy with febrile seizures plus (GEFS+). We studied 132 patients with epilepsy syndromes with seizures precipitated by fever, and performed phenotype-genotype correlations with SCN1A alterations. Methods: We included patients with SMEI including borderline SMEI (SMEB), GEFS+, febrile seizures (FS), or other seizure types precipitated by fever. We performed a clinical and genetic study focusing on SCN1A, using dHPLC, gene sequencing, and MLPA to detect genomic deletions/duplications on SMEI/SMEB patients. Results: We classified patients as: SMEI/SMEB = 55; GEFS+ = 26; and other phenotypes = 51. SCN1A analysis by dHPLC/sequencing revealed 40 mutations in 37 SMEI/SMEB (67%) and 3 GEFS+ (11.5%) probands. MLPA showed genomic deletions in 2 of 18 SMEI/SMEB. Most mutations were de novo (82%). SMEB patients carrying mutations (8) were more likely to have missense mutations (62.5%), conversely SMEI patients (31) had more truncating, splice site or genomic alterations (64.5%). SMEI/SMEB with truncating, splice site or genomic alterations had a significantly earlier age of onset of FS compared to those with missense mutations and without mutations (p = 0.00007, ANOVA test). None of the remaining patients with seizures precipitated by fever carried SCN1A mutations. Conclusion: We obtained a frequency of 71% SCN1A abnormalities in SMEI/SMEB and of 11.5% in GEFS+ probands. MLPA complements DNA sequencing of SCN1A increasing the mutation detection rate. SMEI/SMEB with truncating, splice site or genomic alterations had a significantly earlier age of onset of FS. This study confirms the high sensitivity of SCN1A for SMEI/SMEB phenotypes.

Original languageEnglish
Pages (from-to)1678-1685
Number of pages8
JournalEpilepsia
Volume48
Issue number9
DOIs
Publication statusPublished - Sep 2007

Keywords

  • Fever-provoked seizures
  • GEFS+
  • MLPA
  • SCN1A
  • SMEI

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities'. Together they form a unique fingerprint.

  • Cite this

    Marini, C., Mei, D., Temudo, T., Ferrari, A. R., Buti, D., Dravet, C., Dias, A. I., Moreira, A., Calado, E., Seri, S., Neville, B., Narbona, J., Reid, E., Michelucci, R., Sicca, F., Cross, H. J., & Guerrini, R. (2007). Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia, 48(9), 1678-1685. https://doi.org/10.1111/j.1528-1167.2007.01122.x